Second Roundup Cancer Trial - First On Federal Level - Begins

Mar 1, 2019  | 1 min  | Ep4428

Last year, a California State Court awarded $289 million to DeWayne Johnson, a school groundskeeper who alleged he got cancer from exposure to Monsanto’s Roundup.  The weed killer maker appealed and a judge slashed the award to $78 million.  Johnson accepted the reduction but Monsanto has appealed that decision as well.

Josh Buettner has more on another case against Roundup now entering the court system. Producer

This week a federal trial got underway in San Francisco which could determine the fate of a flurry of similar lawsuits against Monsanto. 

Edwin Hardeman is the second plaintiff to take on the St. Louis-based agribusiness giant, now owned by German-based Bayer AG, over concerns the company’s Roundup weed killer causes cancer.  Hardeman was diagnosed with non-Hodgkin’s lymphoma in 2015.  He claims to have used Roundup on his 56-acre Sonoma County property from the 1980s until 2012.

Monsanto says studies have established Roundup’s active ingredient, glyphosate, is safe.  And the U.S. Environmental Protection Agency has determined the chemical is not harmful when used according to product label directions.

Brent Wisner/Attorney for Plaintiff Edwin Hardeman: “That’s just nonsense.  This company needs to get straight and be honest with its customers and say, listen, there is evidence it’s associated with cancer and let people make a choice about whether or not they use the product.  This case is about failure to warn and the simple fact is they haven’t warned and they’re going to keep being sued until they do.”

The current federal trial is expected to last about one month.  For Market to Market, I’m Josh Buettner.


More from this show

Grinnell Mutual Insurance